Management of anemia in patients with cancer: 2019 Italian Association of Medical Oncology (AIOM) guidelines.

Autor: Sbrana A; Medical Oncology Unit, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy., Antonuzzo A; Medical Oncology Unit, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy., Brunello A; Medical Oncology Unit 1, Istituto Oncologico Veneto, Padua, Italy., Petrelli F; Medical Oncology Unit, ASST Bergamo Ovest, Treviglio, Bergamo, Italy., Pronzato P; Medical Oncology Unit, AOU San Martino IRCCS IST, Genova, Italy., Tralongo A; Medical Oncology Unit, Ospedale di Circolo e Fondazione Macchi, Varese, Italy., Turrini M; Medical Oncology Unit, Ospedale del Valdarno, Santa Maria La Gruccia, Azienda USL Toscana Sud-Est, Montevarchi, Toscana, Italy., Zoratto F; Medical Oncology Unit, Ospedale S. Maria Goretti, Latina, Lazio, Italy., Danova M; Internal Medicine and Medical Oncology, ASST Pavia, Pavia, Lombardia, Italy.
Jazyk: angličtina
Zdroj: Tumori [Tumori] 2020 Oct; Vol. 106 (5), pp. 337-345. Date of Electronic Publication: 2020 Jun 02.
DOI: 10.1177/0300891620921942
Abstrakt: This article summarizes the latest Italian Medical Oncology Association (AIOM) guidelines on the management of cancer-related and chemotherapy-related anemia with a particular attention to the use of erythropoiesis-stimulating agents and iron supplementation.
Databáze: MEDLINE